Home › Breast Cancer › NCT07512271

Generative AI Patient Education Module for Breast Oncology

Accuracy and Effect of Prescribed Generative AI Patient Education Module Within Breast Oncology Care

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Females or males ages 18 and over.
2. Patients must have either:

   1. Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or
   2. Stage I-III breast cancer diagnosed within the past 6 months.
3. Basic computer literacy and regular internet access at home.
4. Able to understand study procedures and to comply with them for the entire length of the study.
5. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

1. Contraindication to any study-related procedure or assessment.
2. Cognitive impairment that would interfere with tool usage or survey completion

About the study

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.

What is being tested

• Survey (Participant) (other)
• OpenEvidence CareConnect (other)
• Survey (Provider) (other)

Sponsor: University of California, San Francisco · Participants: 35 · Started: Jul 14, 2026

Contact the study team

• Ivy Ow · Phone: 877-827-3222

Official record on ClinicalTrials.gov — NCT07512271

Locations in the U.S.

Conditions

• Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.